Xu X - Search Results

1

Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China?

Lai X, Wang X, Yang Q, Xu X, Tang Y, Liu C, Tan L, Lai R, Wang H, Zhang X, Zhou Q, Chen H. Lai X, et al. Among authors: xu x. Antimicrob Resist Infect Control. 2020 Jun 11;9(1):83. doi: 10.1186/s13756-020-00746-1. Antimicrob Resist Infect Control. 2020. PMID: 32527300 Free PMC article.

2

Information Complexity and Behavior Intention to Prescribe Antibiotics Based on the Antimicrobial Susceptibility Testing Report: The Mediating Roles of Information Overload and Attitude.

Wang Y, Zhang X, Zhou Q, Xu X, Liu X, Lu S. Wang Y, et al. Among authors: xu x. Front Pharmacol. 2021 Nov 10;12:778664. doi: 10.3389/fphar.2021.778664. eCollection 2021. Front Pharmacol. 2021. PMID: 34899342 Free PMC article.

3

Impact of selective reporting of antimicrobial susceptibility testing report on clinicians' prescribing behavior of antibiotics.

Wang Y, Zhang X, Zhou Q, Xu X. Wang Y, et al. Among authors: xu x. Front Pharmacol. 2023 Sep 28;14:1225531. doi: 10.3389/fphar.2023.1225531. eCollection 2023. Front Pharmacol. 2023. PMID: 37841913 Free PMC article.

4

The Impact of Information Quality of Antimicrobial Susceptibility Test Report on the Rational Antimicrobial Use: A Retrospective Study.

Wei M, Wang Y, Zhang X, Xu X, Li Y. Wei M, et al. Among authors: xu x. Infect Drug Resist. 2023 Oct 31;16:6965-6974. doi: 10.2147/IDR.S426192. eCollection 2023. Infect Drug Resist. 2023. PMID: 37928604 Free PMC article.

5

Integrated PET/MRI With ¹¹C-CFT and ¹⁸F-FDG for levodopa response difference in Parkinson's disease.

Wu Y, Xu XJ, Sun X, Zhai H, Wang T, Cao XB, Xu Y. Wu Y, et al. Among authors: xu xj, xu y. Behav Brain Res. 2023 Oct 2;454:114609. doi: 10.1016/j.bbr.2023.114609. Epub 2023 Aug 1. Behav Brain Res. 2023. PMID: 37532003

6

Epidemiological features and a survival nomogram for primary lymphoma of the male genital tract.

Xie R, Mao Z, Xu X, Sun T. Xie R, et al. Among authors: xu x. Ann Hematol. 2024 May;103(5):1687-1695. doi: 10.1007/s00277-024-05668-1. Epub 2024 Mar 1. Ann Hematol. 2024. PMID: 38424302

7

¹⁸F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer's Disease.

Xu X, Ruan W, Liu F, Gai Y, Liu Q, Su Y, Liang Z, Sun X, Lan X. Xu X, et al. Front Aging Neurosci. 2022 Feb 10;13:789054. doi: 10.3389/fnagi.2021.789054. eCollection 2021. Front Aging Neurosci. 2022. PMID: 35221982 Free PMC article.

8

Evaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia: a cross-sectional survey.

Chen H, Zhang Y, Jiang Y, Lin L, Cheng S, Xu X, Zhang X, Lin H, Huang Z, Wang Q, Zhou X, Qu H, Liu X, Li W, Xu N. Chen H, et al. Among authors: xu n, xu x. Leuk Lymphoma. 2023 Jul-Aug;64(8):1458-1464. doi: 10.1080/10428194.2023.2217711. Epub 2023 Jun 6. Leuk Lymphoma. 2023. PMID: 37282611

9

Characterizing Early-Onset Alzheimer Disease Using Multiprobe PET/MRI: An AT(N) Framework-Based Study.

Xu X, Ruan W, Liu F, Liu Q, Gai Y, Su Y, Liang Z, Sun X, Lan X. Xu X, et al. Clin Nucl Med. 2023 Jun 1;48(6):474-482. doi: 10.1097/RLU.0000000000004663. Epub 2023 Apr 24. Clin Nucl Med. 2023. PMID: 37075301

10

A prognostication system based on clinical parameters and [¹⁸F]-FDG PET/CT in patients with newly diagnosed multiple myeloma.

Li J, Zhang X, Qin C, Sun X, Xu X, Cao G, Gai Y, Sun C, Hu Y, Lan X. Li J, et al. Among authors: xu x. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1665-1670. doi: 10.1007/s00259-022-06088-x. Epub 2022 Dec 28. Eur J Nucl Med Mol Imaging. 2023. PMID: 36576511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,015 results

Search Page

Filters